Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial.
Sun H, Li M, Huang W, Zhang J, Wei S, Yang Y, Wang Z, Ye S, Gong H, Zhang Y, Li J, Song H, Wang L, Chen X, Lin H, Ding G, Li H, Zheng A, Ma X, Chen S, Liu L, Zhang K, Fu C, Liu W, Wang J, Zhang X, Liu T, Han D, Zhao Q, Wu P, Yuan Q, Tian L, Zhang P, Wu X, Chen F, Zhang Z, Li B.
Sun H, et al. Among authors: tian l.
J Clin Oncol. 2025 Feb;43(4):412-421. doi: 10.1200/JCO.23.02075. Epub 2024 Oct 7.
J Clin Oncol. 2025.
PMID: 39374473
Clinical Trial.